Investing

Betting on Pot in the Stock Market - Canadian Cannabis

Betting on Pot in the Stock Market

Betting on Pot in the Stock Market

Since Justin Trudeau’s election, the Canadian cannabis space has seen significant growth both in public and private sectors. The industry is gearing up for its entry into the legal recreational cannabis market set to open up by July 1, 2018.

Marijuana Index Dips 3% in June as Canadian Stocks Continue to Decline

Marijuana Index Dips 3% in June as Canadian Stocks Continue to Decline

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 3% in June as continued losses in Canada closed out the Index’s second worst performing quarter since its inception in January 2015.

Better Know a Marijuana Stock: MedReleaf Corp.

Better Know a Marijuana Stock: MedReleaf Corp.

MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. today is one of the pre-eminent marijuana producers listed on the TSX Venture Exchange with a market capitalization just shy of $750 million, making it the fourth-largest marijuana stock behind only GW Pharmaceuticals PLC- ADR, Canopy Growth Corp., and Aphria Inc.

Better Know a Marijuana Stock: Arena Pharmaceuticals

Better Know a Marijuana Stock: Arena Pharmaceuticals

Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

Warren Buffett is well known as the most successful investor of all time. Buffett spent his formative years under the tutelage of Benjamin Graham, who is known today as the “father of value investing.” Let’s see whether or not Aphria Inc. can pass Buffett’s mentor’s criteriea test.

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.

SEC Calls Hemp Oil Fraud on Public Company

SEC Calls Hemp Oil Fraud on Public Company

On June 15, 2017, the United States Securities and Exchange Commission called hemp oil fraud on a public company, filing a complaint in federal court that claims CV Sciences (OTCQB:CVSI) , formerly known as CannaVEST, and its CEO, Michael Mona, Jr., intentionally overstated the company’s total assets.

The Very First Cannabis Stock ETF Is Now in Bear-Market Territory

The Very First Cannabis Stock ETF is Now in Bear-Market Territory

The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.

MedMen Opportunity Fund Closes Below $100 Million Target

MedMen Opportunity Fund Closes Below $100 Million Target

On June 12, 2017, the MedMen Opportunity Fund, a California-based private equity fund focused on the legal marijuana industry, filed Form D with the United States Securities and Exchange Commission, indicating that it had raised approximately $60 million of its $100 million offering.

Say Hello to the Largest North American Marijuana Stock IPO

Say Hello to the Largest North American Marijuana Stock IPO

In April, investors were privy to the very first marijuana stock ETF, which debuted on the Toronto Stock Exchange with slightly more than a dozen holdings. This represented the very first time a basket fund was created for investors to easily diversify their pot-stock holdings. And last week, investors witnessed another marijuana first: the largest North American marijuana stock IPO of all-time.

Canadian Cannabis Investors Bogart Deals in America

Canadian Cannabis Investors Bogart Deals in America

There is so much Canadian cannabis investment money right now that it is cascading down into the United States and Canadian investors are easily outbidding domestic acquirers.

Green bubble? Cannabis investors on white-knuckle ride as share prices fall

Green Bubble? Cannabis Investors on White-Knuckle Ride as Share Prices Fall

Canadian marijuana stocks have been on a punishing slide for three straight months despite a temporary blip of investor fever in April that sent share prices soaring to record highs as Ottawa tabled legislation to legalize pot.

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

If there is a “Holy Grail” milestone out there for cannabis stocks, it’s the $1 billion sales mark. The first cannabis company to hit $1 billion in sales will likely validate the industry to Wall Street and investors. But which marijuana stock has the best chance at being first to $1 billion in annual sales?

North American Marijuana Index Drops 15% in May, Worst Performing Month in Over a Year

North American Marijuana Index Drops 15% in May, Worst Month in Over a Year

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 15% in May as stocks sold off in both markets. This marks the worst performing month for the North American Marijuana Index since December 2015.

High Times Acquisition: Company Valued at $70 Million

High Times Acquisition: Company Valued at $70 Million

On June 1, 2017, High Times announced that controlling interest in the company had been acquired by 20 investors, a group comprised of cannabis industry members, entrepreneurs and entertainment veterans. Oreva Capital, a Los Angeles-based investment firm, led the High Times acquisition, valuing the company at $70 million. The company will now operate as High Times Holding Company.

Billion Dollar Fund Manager Targets Cannabis

Billion Dollar Fund Manager Targets Cannabis

First Trust Portfolios filed an S-6 on May 3oth with the Securities and Exchange Commission for a Medical Cannabis Portfolio Series – FT 6766 that is seeking above average capital appreciation.

Canopy Growth Corp.: Are There Any Puffs Left to Smoke?

Canopy Growth Corp.: Are There Any Puffs Left to Smoke?

There are many reasons why Canopyis falling faster than its peers, but a big reason is the fact that Canopy was one of the first firms to the party. Canopy was one of the only ways to invest in the emerging marijuana industry, but now it is just one of many options to get in on the marijuana party.

Marijuana Breathalyzer Company Raises $8.1M in Series B Financing

Marijuana Breathalyzer Company Raises $8.1M in Series B Financing

On May 23, 2017, Hound Labs Inc., a marijuana breathalyzer company in Oakland, announced that it has closed its Series B round of financing with $8.1 million from Benchmark, a California-based venture capital firm that has made successful early-stage investments in companies like Uber and Snapchat, among others.

Two Marijuana Stocks Suspended Temporarily by SEC

Two Marijuana Stocks Suspended Temporarily by SEC

On May 19, 2017, the U.S. Securities and Exchange Commission announced the temporary suspension of two marijuana stocks that trade on the OTC Markets, with both orders of suspension related to the companies neglecting to provide accurate and up-to-date information.

This New Study Should Encourage Marijuana Stock Investors

This New Study Should Encourage Marijuana Stock Investors

The marijuana industry, and marijuana stock investors for that matter, have been expanding by leaps and bounds over the past two decades. One good way to keep this up is through university-based clinical studies. Studies like these really fan the flame of what might be possible with cannabis-based medicines.


Page 3 of 1712345...10...Last »
Top